Electrical Stimulation Blood Pressure Treatment Devices Market 2021 to Witness Notable Growth with Covid-19 Analysis, Revenues Overview with Recent Developments, and Challenges and Future Scope, Forecast 2028

Market Overview:

Electrical stimulation blood pressure treatment prevents atrophy in aging muscles. Because it acts on the nerves, electrical stimulation can help patients regain muscle control after surgery. The electrical impulses can help the brain learn how to contract muscles on its own. If used correctly, electrical stimulation can also prevent muscle atrophy due to inactivity and imbalance.

Get the complete sample, please click: https://www.coherentmarketinsights.com/insight/request-sample/25

Competitive Landscape:

Major players operating in the global electrical stimulation blood pressure treatment devices market include, NeuroMetrix, Inc., Nevro Corporation., Medtronic plc., St. Jude Medical, Inc., DJO Global, Inc., BTL Industries, Inc., Uroplasty, Inc. (Cogentix Medical), LIVANOVA PLC., Zynex, Inc., and Boston Scientific Corporation.

Key Market Drivers:

The global electrical stimulation blood pressure treatment devices market growth is driven by increasing prevalence of hypertension. For instance, according to a cross-sectional, population-based study, ‘Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults’, published in JAMA Internal Medicine in March 2018, the crude prevalence of hypertension in India was 25.3% between 2012 and 2014.

Covid-19 Impact Analysis

Globally, as of 6:45pm CET, 23 November 2021, there have been 257,469,528 confirmed cases of COVID-19, including 5,158,211 deaths, reported to WHO. As of 22 November 2021, a total of 7,408,870,760 vaccine doses have been administered. The pandemic has led to increase in the production of vitals monitoring devices. For instance, in March 2020, Hillrom, Inc. announced that the company is doubling the production of ventilators, hospital beds, and vitals monitoring devices to support Covid-19 response.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/25

Key Takeaways

• Electrical stimulation devices cannot be used for self-injurious or aggressive behavior in the U.S. In March 2020, the U.S. Food and Drug Administration published a final rule to ban electrical stimulation devices used for self-injurious or aggressive behavior because they present an unreasonable and substantial risk of illness or injury.

• Major players operating in the global electrical stimulation blood pressure treatment devices market are focused on adopting merger and acquisition strategies to expand their product portfolio. For instance, in November 2021, Pacira BioSciences, Inc., a provider of non-opioid pain management and regenerative health solutions, acquired Flexion Therapeutics, Inc.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.